RenalytixAI (RENX.L): KidneyIntelX to be used in study investigating kidney risk in COVID-19 Patients
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Renalytix Plc (RENX:LON) | 35.0 0 0.0% | Mkt Cap: 35.0m
- Published:
03 Aug 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
RenalytixAI (RENX.L): KidneyIntelX to be used in study investigating kidney risk in COVID-19 Patients